• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Chelsea Therapeutics International Ltd


Ticker Delisted

As of 03:00:52 ET on 06/24/2014.

Snapshot for Chelsea Therapeutics International Ltd (3CH)

Open: 4.704 Day's Range: 4.696 - 4.704 Volume: 0
Previous Close: 4.720 52wk Range: 1.698 - 5.300 1-Yr Rtn: -

Stock Chart for 3CH

No chart data available.
  • 3CH:GR 4.696
  • 1D
  • 1M
  • 1Y
Interactive 3CH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3CH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3400
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3CH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3CH

Chelsea Therapeutics International Ltd. is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.

Joseph G OlivetoPresident/CEOWilliam D SchwietermanVP/Chief Medical Officer
Keith W SchmidtVP/Chief Commercial OfficerL Arthur HewittVP/Chief Scientific Officer
More Company Profile & Key Executives for 3CH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil